Trends in the Use of Conventional and New Pharmaceuticals for Hemophilia Treatments Among Medicaid Enrollees, 2005-2020

JAMA Netw Open. 2021 Jun 1;4(6):e2112044. doi: 10.1001/jamanetworkopen.2021.12044.

Abstract

This cohort study used Medicaid data to examine trends in the use of and spending for hemophilia pharmaceuticals from 2005 to 2020.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Health Services Accessibility / statistics & numerical data*
  • Hemophilia A / drug therapy*
  • Humans
  • Insurance Coverage / statistics & numerical data
  • Managed Care Programs / standards*
  • Medicaid
  • Patient Satisfaction / statistics & numerical data*
  • Treatment Outcome
  • United States